A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)
Phase of Trial: Phase I/II
Latest Information Update: 20 Nov 2019
Price : $35 *
At a glance
- Drugs Olaparib (Primary) ; Radium 223 chloride (Primary)
- Indications Adenocarcinoma; Bone metastases; Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms COMRADE
- 10 Jun 2019 Status changed from suspended to recruiting.
- 25 Apr 2019 Status changed from recruiting to suspended.
- 24 Jan 2019 Status changed from not yet recruiting to recruiting.